Is a single dose of ChAdOx1 nCoV‐19 vaccine (AZD1222) enough for people with prior SARS‐CoV‐2 infection or baseline seropositive status?
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Elsevier
2022-10-01
|
Colecção: | International Journal of Infectious Diseases |
Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1201971222003848 |